We are live on ! Find out more
BHC

Bowen Hanes & Co Portfolio holdings

AUM $4.11B
1-Year Est. Return 41.61%
This Fund
S&P 500
This Quarter Est. Return
+12.49%
1 Year Est. Return
+41.61%
3 Year Est. Return
+119.85%
5 Year Est. Return
+166.26%
10 Year Est. Return
+656.19%
AUM
$3.54B
AUM Growth
+$288M
Cap. Flow
-$56.4M
Cap. Flow %
-1.59%
Top 10 Hldgs %
24.1%
Holding
163
New
9
Increased
34
Reduced
73
Closed
4

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$40.2M
2
EW icon
Edwards Lifesciences
EW
+$27.7M
3
FDX icon
FedEx
FDX
+$27.7M
4
INTU icon
Intuit
INTU
+$27.2M
5
TRMB icon
Trimble
TRMB
+$26.6M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$36.8M
2
GLW icon
Corning
GLW
+$34.6M
3
CSCO icon
Cisco
CSCO
+$33.1M
4
WMT icon
Walmart Inc
WMT
+$32.7M
5
ERIC icon
Ericsson
ERIC
+$25.9M

Sector Composition

Rank Sector Weight
1 Technology 25.79%
2 Industrials 17.08%
3 Financials 13.45%
4 Healthcare 11.18%
5 Consumer Staples 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACN icon
26
Accenture
ACN
$99.9B
$54.6M 1.54%
131,795
-6,170
-4% -$2.25M
VRT icon
27
Vertiv
VRT
$87.6B
$54.6M 1.54%
2,187,535
+137,885
+7% +$3.45M
V icon
28
Visa
V
$673B
$50.5M 1.42%
233,035
-15,429
-6% -$3.31M
SONY icon
29
Sony
SONY
$134B
$49.6M 1.4%
1,960,695
-75,000
-4% -$1.79M
DIS icon
30
Walt Disney
DIS
$167B
$49.2M 1.39%
317,375
+6,500
+2% +$1.05M
JNJ icon
31
Johnson & Johnson
JNJ
$617B
$48.2M 1.36%
282,025
-77,669
-22% -$12.7M
NDSN icon
32
Nordson
NDSN
$16.4B
$46.9M 1.32%
183,575
+300
+0.2% +$76.7K
LMT icon
33
Lockheed Martin
LMT
$132B
$44.8M 1.26%
125,949
+3,125
+3% +$1.08M
LLY icon
34
Eli Lilly
LLY
$1.03T
$43.8M 1.24%
+158,725
New +$40.2M
UNH icon
35
UnitedHealth
UNH
$383B
$43.6M 1.23%
86,835
+4,950
+6% +$2.24M
JCI icon
36
Johnson Controls International
JCI
$87.8B
$43.4M 1.22%
533,575
+825
+0.2% +$62.4K
PYPL icon
37
PayPal
PYPL
$49.3B
$42.8M 1.21%
227,151
-520
-0.2% -$113K
VRTX icon
38
Vertex Pharmaceuticals
VRTX
$122B
$42.6M 1.2%
194,120
+15,475
+9% +$3.01M
GNRC icon
39
Generac Holdings
GNRC
$11.3B
$39.6M 1.12%
112,430
+13,205
+13% +$5.48M
AXP icon
40
American Express
AXP
$228B
$38.8M 1.1%
237,330
+55,600
+31% +$9.48M
PLD icon
41
Prologis
PLD
$136B
$37.3M 1.05%
221,713
-368
-0.2% -$54.9K
IFF icon
42
International Flavors & Fragrances
IFF
$20.3B
$37.1M 1.05%
246,053
-4,822
-2% -$702K
CNQ icon
43
Canadian Natural Resources
CNQ
$98.6B
$34.1M 0.96%
1,647,976
+626,976
+61% +$12.7M
ABB
44
DELISTED
ABB Ltd
ABB
$33.7M 0.95%
884,094
+266,710
+43% +$9.36M
P
45
Everpure Inc
P
$25B
$31.7M 0.9%
975,000
+75,000
+8% +$2.18M
WY icon
46
Weyerhaeuser
WY
$16.9B
$30.9M 0.87%
751,138
-2,770
-0.4% -$105K
FDX icon
47
FedEx
FDX
$73B
$30.9M 0.87%
119,464
+115,225
+2,718% +$27.7M
EW icon
48
Edwards Lifesciences
EW
$50B
$30.8M 0.87%
+237,530
New +$27.7M
PANW icon
49
Palo Alto Networks
PANW
$265B
$30.7M 0.87%
331,332
+79,332
+31% +$6.86M
GRMN
50
Garmin
GRMN
$57.4B
$29.3M 0.83%
215,000
-7,000
-3% -$1.01M

Similar funds

Bowen Hanes & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Bowen Hanes & Co held 163 positions worth $3.54B, up 8.9% from $3.26B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Bowen Hanes & Co's Q4 2021 filing shows 9 new, 34 increased, 73 reduced and 4 closed positions. Its largest new stake was Eli Lilly: 158,725 shares worth $43.8M. The largest sale was Medtronic, an estimated $36.8M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Industrials and Financials.

  • Bowen Hanes & Co's largest Q4 2021 buy was Eli Lilly: 158,725 shares worth $43.8M.
  • Bowen Hanes & Co added most to FedEx in Q4 2021, an estimated $27.7M increase.
  • Bowen Hanes & Co's biggest Q4 2021 reduction was Medtronic, cutting an estimated $36.8M.
  • Bowen Hanes & Co fully exited Sonos in Q4 2021, selling an estimated $17.8M.
  • Bowen Hanes & Co's ten largest holdings make up 24% of its $3.54B portfolio in Q4 2021.
  • Bowen Hanes & Co opened 9 new positions and closed 4 in Q4 2021.
  • Bowen Hanes & Co's portfolio value rose 8.9% quarter-over-quarter to $3.54B.

Based on Bowen Hanes & Co's 13F filing for Q4 2021, filed 11 Feb 2022.